Income Statement - ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 558.48 | 980.65 | 221.98 | 209.71 | 27.91 | 12.45 | 14.51 | 6.81 | 6.33 | 7.67 |
| Cost of revenue | 131.73 | 29.09 | 30.54 | 22.00 | 3.33 | 1.97 | 2.10 | 0.26 | ||
| Gross profit | 426.75 | 951.57 | 191.44 | 187.71 | 24.58 | 10.48 | 12.42 | 6.81 | 6.33 | 7.41 |
| Total operating expenses | 1,605.91 | 1,321.30 | 1,064.08 | 1,037.52 | 957.75 | 674.43 | 595.10 | 333.33 | 137.00 | 122.03 |
| Operating income | -1,179.16 | -369.73 | -872.64 | -849.81 | -869.84 | -663.94 | -582.69 | -345.44 | -130.67 | -114.62 |
| Non-operating income (net) | -23.21 | -25.53 | -60.23 | -37.36 | 37.59 | -11.51 | -899.63 | -15.00 | 10.55 | 6.78 |
| Income before tax | -1,202.37 | -395.26 | -932.86 | -887.17 | -832.25 | -675.45 | -1,482.32 | -360.44 | -120.12 | -107.84 |
| Income tax expense | 6.75 | 10.43 | -7.15 | -4.25 | -49.83 | 2.16 | -1.60 | -1.60 | -1.60 | |
| Net income | -1,208.91 | -405.43 | -925.64 | -882.92 | -782.42 | -677.61 | -1,480.71 | -345.31 | -118.51 | -107.84 |
Show Quarterly Income Statement
Income Statement - ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
$(Billion, Million)| Mar-26 | Dec-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Dec-22 | Jun-22 | Dec-21 | Jun-21 | Dec-20 | Jun-20 | Dec-19 | Jun-19 | Dec-18 | Jun-18 | Mar-18 | Dec-17 | Jun-17 | Mar-17 | Dec-16 | Jun-16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 334.13 | 334.13 | 233.70 | 156.90 | 156.90 | 78.45 | 823.75 | 411.87 | 79.28 | 39.64 | 142.70 | 104.86 | 104.86 | 14.95 | 12.97 | 6.23 | 6.23 | 7.26 | 7.26 | 5.11 | 1.70 | 0.14 | 6.05 | 0.28 | 0.28 | 3.83 | 3.83 |
| Cost of revenue | 68.69 | 68.69 | 21.65 | 14.03 | 14.03 | 7.01 | 15.06 | 7.53 | 12.39 | 6.20 | 18.15 | 11.00 | 11.00 | 0.74 | 2.59 | 0.98 | 0.98 | 1.05 | 1.05 | -0.50 | 0.50 | 0.50 | -0.28 | 0.28 | 0.28 | 0.13 | 0.13 |
| Gross profit | 265.45 | 265.45 | 212.05 | 142.88 | 142.88 | 71.44 | 808.69 | 404.34 | 66.89 | 33.45 | 124.55 | 93.86 | 93.86 | 14.21 | 10.38 | 5.24 | 5.24 | 6.21 | 6.21 | 5.11 | -0.36 | -0.36 | 6.33 | 0.00 | 0.00 | 3.70 | 3.70 |
| Total operating expenses | 906.30 | 906.30 | 766.03 | 709.66 | 709.66 | 354.83 | 620.70 | 310.35 | 598.96 | 299.48 | 465.12 | 518.76 | 518.76 | 447.21 | 447.21 | 337.21 | 337.21 | 297.55 | 297.55 | 215.65 | 6.84 | 6.84 | 134.53 | 2.47 | 2.47 | 61.01 | 61.01 |
| Operating income | -640.85 | -640.85 | -553.98 | -566.79 | -566.79 | -283.39 | 187.98 | 93.99 | -532.07 | -266.03 | -340.57 | -424.91 | -424.91 | -434.92 | -434.92 | -331.97 | -331.97 | -291.34 | -291.34 | -338.24 | -7.20 | -7.20 | -128.20 | -2.47 | -2.47 | -57.31 | -57.31 |
| Non-operating income (net) | 2.14 | 2.14 | -31.33 | 8.64 | 8.64 | 4.32 | -25.09 | -12.54 | -1.19 | -0.60 | -59.04 | -18.68 | -18.68 | 18.79 | 60.54 | -5.75 | -5.75 | -449.82 | -449.82 | -20.13 | 5.13 | 5.13 | 11.68 | -1.13 | -1.13 | 3.39 | 3.39 |
| Income before tax | -638.72 | -638.72 | -585.31 | -558.15 | -558.15 | -279.08 | 162.90 | 81.45 | -533.26 | -266.63 | -399.60 | -443.59 | -443.59 | -416.12 | -374.38 | -337.72 | -337.72 | -741.16 | -741.16 | -358.37 | -2.07 | -2.07 | -116.52 | -3.60 | -3.60 | -53.92 | -53.92 |
| Income tax expense | 1.40 | 1.40 | 5.51 | 10.36 | 10.36 | 5.18 | 0.07 | 0.03 | -9.90 | -4.95 | 2.75 | -2.12 | -2.12 | -24.91 | -24.91 | 1.08 | 1.08 | -0.80 | -0.80 | 0.80 | -0.06 | -0.06 | -1.54 | -0.06 | -0.06 | ||
| Net income | -639.96 | -639.96 | -590.77 | -568.43 | -568.43 | -284.22 | 163.00 | 81.50 | -523.29 | -261.64 | -402.35 | -441.46 | -441.46 | -391.21 | -391.21 | -338.80 | -338.80 | -740.36 | -740.36 | -343.30 | -2.01 | -2.01 | -114.97 | -3.54 | -3.54 | -53.92 | -53.92 |